Friedrich’s Ataxia

Drug Name: Skyclarys Indications: To treat Friedrich’s ataxia. Active Ingredient: Omaveloxolone Company: Reata Pharmaceuticals Holdings Approval Date: 2/28/2023 More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216718Orig1s000lbl.pdf